One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
Trends in Nephrology: From reducing proteinuria with steroids to curing glomerulonephritis
doi : 10.1093/ndt/gfaf152
Volume 41, Issue 1, January 2026
IDF Diabetes Atlas 11th edition 2025: global prevalence and projections for 2050
doi : 10.1093/ndt/gfaf177
Treatment of diabetes in patients with advanced chronic kidney disease or kidney failure
doi : 10.1093/ndt/gfaf083
Perlecan is a novel target of autoantibodies in anti-glomerular basement membrane disease
doi : 10.1093/ndt/gfaf153
Genotype–phenotype correlations and clinical outcomes of genetic TRPC6 podocytopathies
doi : 10.1093/ndt/gfaf086
Urinary rituximab loss and rate of treatment failure in membranous nephropathy
doi : 10.1093/ndt/gfaf127
Hemodialysis removes protective metabolites and disrupts mitochondrial function
doi : 10.1093/ndt/gfaf145
Association of urinary LIF levels with disease prognosis and treatment response to methylprednisolone in IgA nephropathy
doi : 10.1093/ndt/gfaf164
Simultaneous initiation of finerenone and empagliflozin across the spectrum of kidney risk in the CONFIDENCE trial
doi : 10.1093/ndt/gfaf160
KDIGO 2025 ADPKD guideline: a commentary on diagnosis and management of hepatopancreatic manifestations by the ERA Working Group Genes & Kidney
doi : 10.1093/ndt/gfaf159
Targeting endothelin A and angiotensin type 1 receptors with ambrisentan and losartan ameliorates cisplatin-induced injury in human tubuloids
doi : 10.1093/ndt/gfaf209
